But AI can play a positive role in medical education. THE UNITED STATES
hb```G@(p+PjHQTWO:-:Tp20Wi! CMS and its products and services are not endorsed by the AHA or any of its affiliates. A patient presents with flu-like symptoms. You acknowledge that the ADA holds all copyright, trademark and other rights in CDT. Title XVIII of the Social Security Act (SSA) 1833(e) prohibits Medicare payment for any claim lacking the necessary documentation to process the claim. hbbd```b``z"gIi MD>*{`S`0 CPT code (s): 87804 (x2) Methodology: Optical Immunoassay. The performance characteristics of rapid influenza diagnostic tests vary widely. Shaw MW, Arden NH, Maassab HF. "lV $10120^ &'@ A
The CMS.gov Web site currently does not fully support browsers with
If you do not agree with all terms and conditions set forth herein, click below on the button labeled "I do not accept" and exit from this computer screen. The results were evaluated based on PCR ct values. Similarly, tests (and CPT codes) for which there are no accompanying ICD-10 codes in the associated Billing and Coding Article will require registration with MolDX . an effective method to share Articles that Medicare contractors develop. This instructional video reviews the items included in the McKesson Consult Flu Test Kit and provides an overview of step-by-step instructions for using this test kit. 87637 Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), influenza virus types A and B, and respiratory syncytial virus, multiplex amplified probe technique. CMS believes that the Internet is
Negative . As the only medical association that convenes 190+ state and specialty medical societies and other critical stakeholders, the AMA represents physicians with a unified voice to all key players in health care. Point-of-care tests for influenza Large number on the market - some separate influenza A from influenza B - some specific for influenza H5 Detect either antigen or neuraminidase activity Vary in the number of steps (4-8) and in the time to perform the test (10-30 mins) The AMA is a third party beneficiary to this Agreement. Before sharing sensitive information, make sure you're on a federal government site. You can use the Contents side panel to help navigate the various sections. Federal government websites often end in .gov or .mil. What is the CMS suggested CPT code and National Limit for the Sofia Influenza A+B FIA? This email will be sent from you to the
Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes,
"JavaScript" disabled. End Users do not act for or on behalf of the CMS. R5. Follow manufacturers instructions, including handling of respiratory specimens, as described in the device package insert. Reference: Centers for Disease Control and Prevention. complete information, CMS does not guarantee that there are no errors in the information displayed on this web site. Revision Explanation: Under CPT/HCPCS Codes Group 1: Codes the description was revised for 87400. Alternative name (s): Influenza A&B EIA; Rapid Flu; Rapid Influenza. All SARS-CoV-2 samples were expected to be Omicron sublineage according to the current epidemiological situation in Belgium. testing to when the result is released to the ordering provider. The program covers drugs that are furnished "incident-to" a physician's service provided that the drugs are not "usually self-administered" by the patient. An official website of the United States government. DISCLOSED HEREIN. The American Hospital Association ("the AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. . Test Includes. All Rights Reserved. 87804-QW, infectious agent antigen detection by immunoassay with direct optical observation; influenza. Submit one specimen per test requested. Neither the United States Government nor its employees represent that use of such information, product, or processes
In individuals with symptoms, the Lucira COVID-19 & Flu Home Test correctly identified 99.3% of negative and 90.1% of positive Influenza A samples, 100% of negative and 88.3% of positive COVID-19 . The new additions and revisions to the CPT code set have been approved for immediate use. In addition, we will perform experimental evolution in Escherichia coli and influenza to test hypotheses related to the change of fitness effects across environments, and to adaptation by means of highly epistatic mutations. Local Coverage Articles are a type of educational document published by the Medicare Administrative Contractors (MACs). will not infringe on privately owned rights. No portion of the American Hospital Association (AHA) copyrighted materials contained within this publication may be
Will the QuickVue Influenza A+B Test specify that a patient has avian influenza? The CPT Editorial Panel also revised CPT codes ranging from 87301 to 87430 by removing . Please enable "JavaScript" and revisit this page or proceed with browsing CMS.gov with
2016;54(11):2763-2766. Use is limited to use in Medicare, Medicaid or other programs administered by the Centers for Medicare and Medicaid Services (CMS). A patient has had recent close exposure (this does NOT include eating cooked meat) to pigs or birds (including poultry) or other animals, and there is concern for infection with a novel influenza A virus. Please enable "JavaScript" and revisit this page or proceed with browsing CMS.gov with
0. 2021 Laboratory Corporation of America Holdings and Lexi-Comp Inc. All Rights Reserved. This Agreement will terminate upon notice if you violate its terms. You are leaving the CMS MCD and are being redirected to the CMS MCD Archive that contains outdated (No Longer In Effect) Local Coverage Determinations and Articles, You are leaving the CMS MCD and are being redirected to, Billing and Coding: Influenza Diagnostic Tests, AMA CPT / ADA CDT / AHA NUBC Copyright Statement, Less sensitive (50%-70%) and specific (90%-95%) compared to other methods and may require confirmation by. The suggested*** CPT codes are: Influenza A: 87804 . In no event shall CMS be liable for direct, indirect, special, incidental, or consequential
You must log in or register to reply here. A and B are separate results/separate tests. In addition to the long descriptors, short and medium descriptors for CPT codes 87636, 87637, 87426 and 87811 can be accessed on the AMA website, along with several other recent modifications to the CPT code set that have helped streamline the public health response to the SAR-CoV-2 virus and the COVID-19 disease. Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. Shell vials or equivalent multiwell plate cell culture; identification (additional CPT codes/charges will apply) if culture results warrant. Learn more with the AMA. Catalog No. Centers for Disease Control and Prevention (CDC) recommendations: Use rapid diagnostic tests with high sensitivity and specificity. Effective March 5, 2020. Influenza Viruses Detected Influenza A Virus Subtypes Differentiated Other Respiratory Viruses Differentiated Approved Specimens 3 Test Time 4; High, Moderate: BioFire Diagnostics, LLC (Commercially Available) BioFire Respiratory Panel 2.1 (RP2.1) Nucleic Acid Detection: FILMARRAY 2.0 and FILMARRAY TORCH systems: Influenza A, Influenza B: A . Accessed 4/27/21. Access reports from the Council on Medical Education presented during the AMA Annual and Interim Meetings. The American Medical Association is the physicians powerful ally in patient care. The Sofia Influenza A+B FIA has been shown to detect cultured human isolates of H5N1; as with other rapid tests for influenza, the ability of the Sofia . The views and/or positions presented in the material do not necessarily represent the views of the AHA. Sometimes, a large group can make scrolling thru a document unwieldy. THIS MAY REPRESENT A DIFFERENT SESSION OR PATIENT ENCOUNTER, DIFFERENT PROCEDURE OR SURGERY, DIFFERNET SITE OR ORGAN SYSTEM, SEPARATE INCISION/EXCISION, SEPARATE LESION, OR SEPARATE INJURY (OR AREA OF INJURY IN EXTENSIVE INJURIES) NOT ORDINARILY ENCOUNTERED OR PERFORMED ON THE SAME DAY BY THE SAME PHYSICIAN. Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. If a CLIA-waived test is performed, the -QW modifier should be reported for the waived test. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or
We code 87804 and 87804-59 if both A and B are tested and results documented. The listed CPT codes reflect Mayo Clinic Laboratories interpretation of CPT coding requirements. The association also released CPT codes for two antigen tests for the COVID-19 . Also, you can decide how often you want to get updates. complete information, CMS does not guarantee that there are no errors in the information displayed on this web site. This Agreement will terminate upon notice if you violate its terms. There are different article types: Articles are often related to an LCD, and the relationship can be seen in the "Associated Documents" section of the Article or the LCD. Find an overview of AMA efforts and initiatives to help improv GME. $7,252.00 / Case of 12 PK. "JavaScript" disabled. HOWEVER, WHAN ANOTHER ALREADY ESTABLISHED MODIFIER IS APPROPRIATE IT SHOULD BE USED RATHER THAN MODIFIER -59. COVID-19/Flu A&B test is intended to aid in the rapid differential diagnosis of Influenza A, B, and SARS-CoV-2 viral infection. If you are experiencing any technical issues related to the search, selecting the 'OK' button to reset the search data should resolve your issues. copied without the express written consent of the AHA. The Alinity m Resp-4-Plex assay was validated with nasopharyngeal swabs. Specimens should be placed into viral transport medium and kept cold at all times. Rapid Immunoassay for Direct Detection and . ONLY IF NO MORE DESCRIPTIVE MODIFIER IS AVAILABLE, AND THE USE OF MODIFIER -59 BEST EXPLAINS THE CIRCUMSTANCES, SHOULD MODIFIER -59 BE USED. AHA copyrighted materials including the UB‐04 codes and
THE UNITED STATES
Federal government websites often end in .gov or .mil. CMS has defined "not usually self-administered" according to how the Medicare population as a whole uses the drug, not how an individual patient or physician may choose to use a particular drug. You need modifer -QW for Medicare patients. Not every residency match is made to last, as more than 1,000 residents transfer programs each year. However, testing is not needed for all outpatients with signs and symptoms consistent with influenza before making antiviral treatment decisions, particularly once influenza activity has been documented in the community. It is typified by the Quidel's QuickVue Influenza test. Rapid qualitative test that detects Influenza type A and type B antigens directly from nasal swab, nasopharyngeal swab, and Nasopharyngeal aspirate / wash specimens. While every effort has been made to provide accurate and
recipient email address(es) you enter. When community influenza activity is high and the rapid diagnostic test result is negative. If your session expires, you will lose all items in your basket and any active searches. There are multiple ways to create a PDF of a document that you are currently viewing. To avoid the overuse of antibiotics and the potential risk of antibiotic resistance, point of care providers should consider testing patients prior to prescribing treatment for a bacterial or influenza infection. Telehealth provides a way for physicians to provide care while keeping patients safe in their homes. Consider sending respiratory specimens (from symptomatic patients) for RT-PCR to confirm results of RIDTs, especially in the following situations: When community influenza activity is low and the rapid diagnostic test result is positive. Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled "I Accept". FDA) now requires that all Rapid influenza diagnostic tests (RIDTs) achieve 80% or higher sensitivity compared with RT-PCR. $634.00 / Pack of 25. These tests provide results in 10-15 minutes and differentiate between influenza A and B. Contractors may specify Bill Types to help providers identify those Bill Types typically
323 0 obj
<>
endobj
accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the
ICD-9 code for sports physicals. Chartrand et al, Accuracy of Rapid Influenza Diagnostic Tests A Meta-analysis; Ann-Intern Med. It may not display this or other websites correctly. article does not apply to that Bill Type. All rights reserved. Response to Comment (RTC) articles list issues raised by external stakeholders during the Proposed LCD comment period. Draft articles have document IDs that begin with "DA" (e.g., DA12345). CONTENTS: 25 Test Cassettes, 25 Sterile Swabs, 25 Extraction Reagent Capsules, 1 Positive Control Swab, 1 Negative Control Swab, 1 Procedure Card, 1 Instructions for Use. We called Medicare and they said. AMA has new CPT codes for dual flu-COVID-19 tests. 2037665 Test code: 97636. Content And Storage. preparation of this material, or the analysis of information provided in the material. Another option is to use the Download button at the top right of the document view pages (for certain document types). and, driving the future of medicine to tackle the biggest challenges in health care. THIS MAY REPRESENT A DIFFERENT SESSION OR PATIENT ENCOUNTER, DIFFERENT PROCEDURE OR SURGERY, DIFFERNET SITE OR ORGAN SYSTEM, SEPARATE INCISION/EXCISION, SEPARATE LESION, OR SEPARATE INJURY (OR AREA OF INJURY IN EXTENSIVE INJURIES) NOT ORDINARILY ENCOUNTERED OR PERFORMED ON THE SAME DAY BY THE SAME PHYSICIAN. The page could not be loaded. damages arising out of the use of such information, product, or process. CPT coding for microbiology and virology procedures often cannot be . 8,384. f Zhq,3&,w+0bv ]LL Reproduced with permission. You can collapse such groups by clicking on the group header to make navigation easier. authorized with an express license from the American Hospital Association. RT-PCR or other amplification methods to detect viral nucleic acids, Results available in < 24 hours (often in less than 2-4 hours), Detects from 1-2 to up to 20 respiratory pathogens from 1 specimen. GOVERNMENT AND ITS EMPLOYEES ARE NOT LIABLE FOR ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION, PRODUCT, OR PROCESSES
Immunofluorescence (IF) - Direct (DFA) or Indirect (IFA) Fluorescent Antibody Staining (antigen detection): If a rapid antigen test is performed and then confirmed using PCR, the second test may require the -59 modifier. Billing & Coding. Use is limited to use in Medicare, Medicaid or other programs administered by the Centers for Medicare and Medicaid Services (CMS). Do not freeze specimens. A patient has had recent close exposure (this does NOT include eating cooked meat) to pigs or birds (including poultry) or other animals, and there is concern for infection with a novel influenza A virus. For quick reference, the new category I CPT codes and long descriptors are: 87636 Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus types A and B, multiplex amplified probe technique, 87637 Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), influenza virus types A and B, and respiratory syncytial virus, multiplex amplified probe technique. Do not use transport devices beyond their expiration date. Council on Long Range Planning & Development, What doctors wish patients knew about long COVID-19 brain fog, Why Minnesota changed key query to promote physician well-being, Want to switch residency programs? Rapid qualitative test that detects Influenza type A and type B antige . Indicate a specific test number on the test request form. Consider sending respiratory specimens (from symptomatic patients) for RT-PCR to confirm results of RIDTs, especially in the following situations: When community influenza activity is low and the rapid diagnostic test result is positive. 1. Information for Clinicians on Rapid Diagnostic Testing for Influenza. SOFIA Influenza rapid test demonstrated good specificity and low sensitivity compared with a nucleic acid test for influenza A, subtype H3, and for influenza B. SOFIA Influenza A + B test performed well in providing a rapid diagnosis, however, confirmatory molecular testing is recommended for negative test results. that coverage is not influenced by Revenue Code and the article should be assumed to apply equally to all Revenue Codes. Self-Administered Drug (SAD) Exclusion List articles list the CPT/HCPCS codes that are excluded from coverage under this category. 87636: Infectious agent detection by nucleic acid (DNA or RNA); severe . Articles often contain coding or other guidelines that are related to a Local Coverage Determination (LCD). There is a risk of false negative for flu A, B, RSV, and SARS-CoV-2 results under certain co-infection circumstances with Pneumocystis jirovecii (PJP). The views and/or positions presented in the material do not necessarily represent the views of the AHA. Learn more. Background. The American Medical Association updated its Current Procedural Terminology set to include updates to coding for tests that detect influenza and . External controls. Specify the exact specimen source/origin (eg, nasopharynx). recommending their use. Neither the United States Government nor its employees represent that use of such information, product, or processes
The American Hospital Association ("the AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. However, please note that once a group is collapsed, the browser Find function will not find codes in that group. Sign up to get the latest information about your choice of CMS topics in your inbox. Waner JL, Todd, SI, Shalaby H, et al. The code joins other COVID-19 testing codes already approved by the CPT Editorial Panel, an independent body convened by the AMA that has the sole authority to expedite the review of proposed changes and additions to the CPT code set. Information for Clinicians on Rapid Diagnostic Testing for Influenza. Any questions pertaining to the license or use of the CPT should be addressed to the AMA. October 07, 2020 - In response to the COVID-19 pandemic, the American Medical Association (AMA) is adding two new codes to the Current Procedural Terminology (CPT) code set. Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. Best answers. Molnlycke Exufiber absorption comparison. This article is being revised in order to adhere to CMS requirements per chapter 13, section 13.5.1 of the Program Integrity Manual. of the Medicare program. CPT coding for microbiology and virology procedures often cannot be determined before the culture is performed. presented in the material do not necessarily represent the views of the AHA. 352 0 obj
<>stream
Harmon MW, Kendal AP. Previous video. The scope of this license is determined by the AMA, the copyright holder. Intended for the qualitative detection ofinfluenza type A and type B nucleoproteinantigens directly from nasal andnasopharyngeal swab specimens frompatients with signs and symptoms ofrespiratory infection. As laboratory tests, Medicare will cover these codes at 100% of their allowed amount with no deductible or coinsurance applied. By clicking below on the button labeled "I accept", you hereby acknowledge that you have read, understood and agreed to all terms and conditions set forth in this agreement. As long as your test in the office checks for both the A and B strains, you can bill for two tests (CPT 87804 and add modifier 59 to the second test as the previous reply mentions). An asterisk (*) indicates a
Streamlines laboratory operations. No. AHA copyrighted materials including the UB‐04 codes and
Response to Comment (RTC) articles list issues raised by external stakeholders during the Proposed LCD comment period. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL CONTAINED ON THIS PAGE. You can use your browser's Print function (Ctrl-P on a PC or Command-P on a Mac) to view a print preview and then select PDF as the output. The May 2009 issue of CPT Assistant provided some guidance regarding this in the article, "Coding Brief: Rapid Influenza Virus A and B Testing (Code 87804)." The coding brief noted that direct optical observation "is a testing platform that yields a typi- without the written consent of the AHA. recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. Information for Clinicians on Rapid Diagnostic Testing for Influenza. Version 2.74 You acknowledge that the ADA holds all copyright, trademark and other rights in CDT. This study evaluated the BD Veritor System Flu A+B (Veritor; BD Diagnostics, Sparks, MD, USA), Quidel Sofia Influenza A+B FIA (Sofia; Quidel Corp., San Diego, CA, USA), and Alere BinaxNOW Influenza A&B (Binax; Alere Scarborough, Inc., Scarborough, ME, USA) compared to reverse transcription-polymerase . All Rights Reserved. However, please note that once a group is collapsed, the browser Find function will not find codes in that group. In addition to SARS-CoV-2 and RSV, the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test can detect influenza . The page could not be loaded. Color-coded control swab packaging for easy positive/negative . CMS and its products and services are
Under Article Text subheading Reference the access date was . License to use CPT for any use not authorized herein must be obtained through the AMA, CPT Intellectual Property Services, AMA Plaza 330 N. Wabash Ave., Suite 39300, Chicago, IL 60611-5885. registered for member area and forum access. Billing and Coding articles provide guidance for the related Local Coverage Determination (LCD) and assist providers in submitting correct claims for payment. According to the FDA, in individuals with symptoms, the home test correctly identified 99.3% of negative and 90.1% of positive Influenza A samples, 100% of negative and 88.3% of positive COVID-19 . In the United States, a number of RIDTs are commercially available. Instructions for enabling "JavaScript" can be found here. 0
CDT is a trademark of the ADA. used to report this service. our vaccine rep inform us to code 87804 and 87804(-91) because we are billing for both A and B. we just started to bill this, not sure of reimbursement yet. Billing and Coding articles typically include CPT/HCPCS procedure codes, ICD-10-CM diagnosis codes, as well as Bill Type, Revenue, and CPT/HCPCS Modifier codes. You can use the Contents side panel to help navigate the various sections. The AMA is your steadfast ally from classroom to Match to residency and beyond. Reference: Centers for Disease Control and Prevention. Rapid influenza diagnostic tests (RIDTs) RIDTs, also called flu antigen tests, are the most common type of flu test. Some older versions have been archived. License to use CPT for any use not authorized herein must be obtained through the AMA, CPT Intellectual Property Services, AMA Plaza 330 N. Wabash Ave., Suite 39300, Chicago, IL 60611-5885. If a CLIA-waived test is performed, the -QW modifier should be reported for the waived test. In most instances Revenue Codes are purely advisory. The LOINC codes are copyright 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. MODIFIER CODE 09959 MAY BE USED AS AN ALTERNATE TO MODIFIER -59. If you would like to extend your session, you may select the Continue Button. Follow manufacturers instructions, including handling of respiratory specimens, as described in the device package insert. This revision is due to the 2022 Annual CPT/HCPCS Code Update and is effective on 1/1/2022. CMS takes big steps to fix prior authorization in Medicare Advantage and more in the latest Advocacy Update spotlight. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. If you are acting on behalf of an organization, you represent that you are authorized to act on behalf of such organization and that your acceptance of the terms of this agreement creates a legally enforceable obligation of the organization. Use modifier 59 when separate results are reported for different species or strains, same laboratory test on the same day to obtain subsequent test results. 23-043-070. Complete absence of all Revenue Codes indicates
The Centers for Medicare & Medicaid Services (CMS), the federal agency responsible for administration of the Medicare,
You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials. The code lists in the article help explain which services (procedures) the related LCD applies to, the diagnosis codes for which the service is covered, or for which the service is not considered reasonable and necessary and therefore not covered. This rigorous editorial process keeps the CPT code set current with contemporary medical science and technology, so it can fulfill its vital role as the trusted language of medicine today and the code to its future. The physician makes the determination to run both influenza A and B tests and a rapid . Some tests are waived from requirements under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and cleared for point-of-care use. ICD-10-CM Codes that Support Medical Necessity, ICD-10-CM Codes that DO NOT Support Medical Necessity, Information for Clinicians on Rapid Diagnostic Testing for Influenza, VIRUS ISOLATION; TISSUE CULTURE INOCULATION, OBSERVATION, AND PRESUMPTIVE IDENTIFICATION BY CYTOPATHIC EFFECT, VIRUS ISOLATION; TISSUE CULTURE, ADDITIONAL STUDIES OR DEFINITIVE IDENTIFICATION (EG, HEMABSORPTION, NEUTRALIZATION, IMMUNOFLUORESCENCE STAIN), EACH ISOLATE, VIRUS ISOLATION; CENTRIFUGE ENHANCED (SHELL VIAL) TECHNIQUE, INCLUDES IDENTIFICATION WITH IMMUNOFLUORESCENCE STAIN, EACH VIRUS, INFECTIOUS AGENT ANTIGEN DETECTION BY IMMUNOFLUORESCENT TECHNIQUE; INFLUENZA B VIRUS, INFECTIOUS AGENT ANTIGEN DETECTION BY IMMUNOFLUORESCENT TECHNIQUE; INFLUENZA A VIRUS, INFECTIOUS AGENT ANTIGEN DETECTION BY IMMUNOASSAY TECHNIQUE (EG, ENZYME IMMUNOASSAY [EIA], ENZYME-LINKED IMMUNOSORBENT ASSAY [ELISA], FLUORESCENCE IMMUNOASSAY [FIA], IMMUNOCHEMILUMINOMETRIC ASSAY [IMCA]), QUALITATIVE OR SEMIQUANTITATIVE; INFLUENZA, A OR B, EACH, INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); INFLUENZA VIRUS, INCLUDES REVERSE TRANSCRIPTION, WHEN PERFORMED, AND AMPLIFIED PROBE TECHNIQUE, EACH TYPE OR SUBTYPE, INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); INFLUENZA VIRUS, FOR MULTIPLE TYPES OR SUB-TYPES, INCLUDES MULTIPLEX REVERSE TRANSCRIPTION, WHEN PERFORMED, AND MULTIPLEX AMPLIFIED PROBE TECHNIQUE, FIRST 2 TYPES OR SUB-TYPES, INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); INFLUENZA VIRUS, FOR MULTIPLE TYPES OR SUB-TYPES, INCLUDES MULTIPLEX REVERSE TRANSCRIPTION, WHEN PERFORMED, AND MULTIPLEX AMPLIFIED PROBE TECHNIQUE, EACH ADDITIONAL INFLUENZA VIRUS TYPE OR SUB-TYPE BEYOND 2 (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE), INFECTIOUS AGENT ANTIGEN DETECTION BY IMMUNOASSAY WITH DIRECT OPTICAL (IE, VISUAL) OBSERVATION; INFLUENZA. Two of the newly approved codes report nucleic acid assays that allow a single test to simultaneously detect the novel coronavirus and a combination of common viral infectious agents, including influenza A/B and respiratory syncytial virus, said AMA President Susan R. Bailey, M.D. 3M Rapid Detection Flu A + B Test: A new diagnostic test for rapid detection of influenza A and influenza B. Mol Diagn Ther. You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement. Please do not use this feature to contact CMS. (CPT) code(s) information for each test or profile. * For positive Flu only or RSV only. The client will not be telephoned to approve this charge. This revision affects the newly developed descriptor for CPT code 87426.